ClinicalTrials.Veeva

Menu

Auriculotherapy Treatment in Fibromyalgia (Fib-Auric)

H

Hopital Foch

Status

Completed

Conditions

Fibromyalgia

Treatments

Other: non-specific auriculotherapy
Other: Specific auriculotherapy
Other: seed auriculotherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT02764788
2015/27
2015-A01842-47 (Other Identifier)

Details and patient eligibility

About

Fibromyalgia (FM) is the most common cause of diffuse pain in the bones and joints, and one of the most frequent causes of referral to the pain management unit. It affects mainly women; they are referred by a rheumatologist, an internal medicine physician or by their family physician.

FM produces various degrees of disability and pain, and has an important impact on quality of life. Sleep disorders, fatigue and cognitive dysfunctions are almost always part of the clinical presentation. The wide range of symptoms and signs, the unknown etiology, the lack of efficacy of pharmacological treatments make management of FM a very difficult task. In France the consensus includes limitation of pharmacological treatment, encouraging physical rehabilitation and referring the patients to a specialized pain clinic where multidisciplinary management will be undertaken. In our hospital the investigators favor non pharmacological therapies and propose to the FM patients to learn relaxation and self-hypnosis, physical rehabilitation and use of trans cutaneous electrical neurostimulation.

Auriculotherapy (AT) is a complementary therapy, based on the idea that the ear is a microsystem which reflects the entire body, represented on the auricle, the outer portion of the ear. Mapping of the auricle has been described, according to the fact that pathology of different organs can induce specific changes in the auricle, for example color change or sensitivity. Treating specific areas, which somehow would be "connected" to the affected organ could also improve the functioning of the body or relieve pain. AT uses placement of needles at points tailored to the patient's pathology. Whatever the mechanisms involved, the effectiveness of ATis currently supported by randomized controlled trials. It is validated by WHO since 1987, mapped in an international nomenclature initially proposed by Nogier.

The investigators regularly use AT in FM patients in our pain management unit to alleviate symptoms as pain, sleep disorders, anxiety. The investigators established a clinical trial in this population to assess impact of FM (assessed with Fibromyalgia Impact Questionnaire) following 3 months of AT management (Primary Outcome). Sleep disorder, fatigue, anxiety and depression, cognitive and physical dysfunction are also evaluated as secondary outcomes. The remnant effect of AT is also evaluated, 3 month after the end of the treatment by the same tests.

Enrollment

100 patients

Sex

Female

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • fibromyalgia (criteria from ACR)

Exclusion criteria

  • history or existing of inflammatory rheumatims, lupus, systemic diseases that may explain the pain syndrom
  • history or existing of severe psychiatric desorder
  • history or existing of hemophilia
  • with anticoagulant treatment
  • local counterindication to auriculotherapy
  • valvular prosthesis
  • auriculotherapy during the last 12 months
  • new psychotherpeutic treatment which interfer with auriculotherapy
  • pregnancy
  • breath feeding
  • RMI for the next 5 months

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

100 participants in 3 patient groups, including a placebo group

Specific auriculotherapy
Experimental group
Description:
Auriculotherapy on specific points with needles
Treatment:
Other: Specific auriculotherapy
Non-specific auriculotherapy
Sham Comparator group
Description:
Auriculotherapy on non-specific auriculotherapy points with needles
Treatment:
Other: non-specific auriculotherapy
Seed auriculotherapy
Placebo Comparator group
Description:
Auriculotherapy on non-specific auriculotherapy points with seeds
Treatment:
Other: seed auriculotherapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems